[Clinical assessment of Gludiase in treatment of diabetes].
D001786:Blood Glucose / Q000032:analysis; D002271:Carbutamide / Q000627:therapeutic use; D002747:Chlorpropamide / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004361:Drug Tolerance; D005260:Female; D006029:Glycosuria / Q000175:diagnosis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D013449:Sulfonamides / Q000627:therapeutic use*; D013830:Thiadiazoles / Q000627:therapeutic use; D013997:Time Factors
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D013449:Sulfonamides; D013830:Thiadiazoles; D002271:Carbutamide; D002747:Chlorpropamide
Kliniczna ocena preparatu gludiaza w leczeniu cukrzycy.